Weight-loss Drugs: Who, and What, Are They Good For?
Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to...
Stay updated with breaking news from Linical Studies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to...
This is the first approved treatment for wounds associated with JEB and the second for patients with DEB, following the approval of a topical gene therapy in May 2023.
An analysis indicates that patients with fairly brisk walking are at a 24% lower risk for type 2 diabetes than those with easy or casual walking.
Neuroinflammation expert Jarred Younger, PhD, disputes commentary calling for clinicians to stop prescribing the off-label compounded medication to reduce pain in people with fibromyalgia.
Promising preclinical and early clinical data suggest a role for GLP-1 receptor agonist therapy in treating alcohol use disorder.